GABA Signaling in Health and Disease in the Nervous System
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: closed (30 March 2024) | Viewed by 13081
Special Issue Editors
Interests: stem cells; sci; genome; CRISPR associated endonuclease Cas9; gene editing; electrocorticography; high frequency oscillation; seizures
Special Issues, Collections and Topics in MDPI journals
Interests: electrophysiology, neuropharmacology and histopathology of local circuit excitatory and inhibitory neurons in cortical regions; focusing on the glutamate and GABAA receptors and transporters
Special Issue Information
Dear Colleagues,
Gabaergic signaling is essential in the brain throughout development, adulthood, and aging. Indeed, gamma-aminobutyric acid (GABA) is involved in processes, such as proliferation, migration, and differentiation of neural progenitor cells, during neurodevelopment. Moreover, GABA was shown to control neuritogenesis and maturation of synapses. In the mature brain, GABA is considered the main inhibitory neurotransmitter, contributing to the excitatory/inhibitory balance. In fact, changes in this balance are often related to neuronal disorders and aging-related neurodegenerative diseases. Moreover, recent reports described hippocampal inhibitory neurons playing unsuspected roles, such as coding space and speed. Considering all this information, authors are invited to contribute to this relevant topic in neuroscience.
Dr. Alexandre Hiroaki Kihara
Prof. Dr. Afia B. Ali
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gamma-aminobutyric acid
- neurodevelopment
- neuronal differentiation
- neuronal disorders
- neurodegenerative diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.